Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kristina Jonsson-Schmunk, Romi Ghose & Maria A. Croyle. (2021) Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A. Expert Review of Vaccines 20:5, pages 623-634.
Read now
Read now
Karina Cunha e Rocha, Beatriz Maria Veloso Pereira & Alice Cristina Rodrigues. (2018) An update on efflux and uptake transporters as determinants of statin response. Expert Opinion on Drug Metabolism & Toxicology 14:6, pages 613-624.
Read now
Read now
Articles from other publishers (17)
John M. Rogers, Melissa M. Heintz, Chad M. Thompson & Laurie C. Haws. (2023) A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per‐ and polyfluoroalkyl substances and relevance to human health. Birth Defects Research.
Crossref
Crossref
Blessed W Aruldhas, Sara K Quinney, Senthil Packiasabapathy, Brian R Overholser, Olivia Raymond, Sahana Sivam, Inesh Sivam, Sanjana Velu, Antoinette Montelibano & Senthilkumar Sadhasivam. (2023) Effects of oxycodone pharmacogenetics on postoperative analgesia and related clinical outcomes in children: a pilot prospective study. Pharmacogenomics 24:4, pages 187-197.
Crossref
Crossref
Shiwei Zhou & Yan Shu. (2022) Transcriptional Regulation of Solute Carrier Drug Transporters. Drug Metabolism and Disposition 50:9, pages 1238-1250.
Crossref
Crossref
Anna Zerdoug, Marc Le Vée, Shotaro Uehara, Béatrice Lopez, Christophe Chesné, Hiroshi Suemizu & Olivier Fardel. (2022) Contribution of Humanized Liver Chimeric Mice to the Study of Human Hepatic Drug Transporters: State of the Art and Perspectives. European Journal of Drug Metabolism and Pharmacokinetics 47:5, pages 621-637.
Crossref
Crossref
Yuan Xu, Jian Lu, Yuanqing Guo, Yuanjin Zhang, Jie Liu, Shengbo Huang, Yanfang Zhang, Liangcai Gao & Xin Wang. (2022) Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in rats. Toxicology Letters 364, pages 1-11.
Crossref
Crossref
Nichole R. Vansell. (2022) Mechanisms by Which Inducers of Drug Metabolizing Enzymes Alter Thyroid Hormones in Rats. Drug Metabolism and Disposition 50:4, pages 508-517.
Crossref
Crossref
Gerd A. Kullak-Ublick. (2021) Nukleäre Rezeptoren beim hepatischen und intestinalen Medikamententransport. Drug Research 71:S 01, pages S13-S14.
Crossref
Crossref
Jenni Küblbeck, Jonna Niskanen & Paavo Honkakoski. (2020) Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR. Cells 9:10, pages 2306.
Crossref
Crossref
Dahea You, Jason R. Richardson & Lauren M. Aleksunes. (2020) Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition. Drug Metabolism and Disposition 48:6, pages 459-480.
Crossref
Crossref
Katsuaki Ito, Noora Sjöstedt, Melina M. Malinen, Cen Guo & Kim L.R. Brouwer. (2020) Hepatic Transporter Alterations by Nuclear Receptor Agonist T0901317 in Sandwich-Cultured Human Hepatocytes: Proteomic Analysis and PBPK Modeling to Evaluate Drug-Drug Interaction Risk. Journal of Pharmacology and Experimental Therapeutics 373:2, pages 261-268.
Crossref
Crossref
Jingwei Zhang, Zhenzhen Zhao, Hao Bai, Minjin Wang, Lin Jiao, Wu Peng, Tao Wu, Tangyuheng Liu, Hao Chen, Xingbo Song, Lijuan Wu, Xuejiao Hu, Qian Wu, Juan Zhou, Jiajia Song, Mengyuan Lyv & Binwu Ying. (2019) Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury. PLOS ONE 14:9, pages e0222033.
Crossref
Crossref
Lei Zhang, Peipei Xu, Yi Cheng, Peili Wang, Xinrun Ma, Mingyao Liu, Xin Wang & Feng Xu. (2019) Diet-induced obese alters the expression and function of hepatic drug-metabolizing enzymes and transporters in rats. Biochemical Pharmacology 164, pages 368-376.
Crossref
Crossref
Laure-Alix Clerbaux, Alicia Paini, Annie Lumen, Hanan Osman-Ponchet, Andrew P. Worth & Olivier Fardel. (2019) Membrane transporter data to support kinetically-informed chemical risk assessment using non-animal methods: Scientific and regulatory perspectives. Environment International 126, pages 659-671.
Crossref
Crossref
Raymond Evers, Micheline Piquette-Miller, Joseph W. Polli, Frans G.M. Russel, Jason A. Sprowl, Kimio Tohyama, Joseph A. Ware, Saskia N. de Wildt, Wen Xie & Kim L.R. Brouwer. (2018) Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium. Clinical Pharmacology & Therapeutics 104:5, pages 900-915.
Crossref
Crossref
Ella Bhagyaraj, Drishti Tiwari, Nancy Ahuja, Ravikanth Nanduri, Ankita Saini, Rashi Kalra, Sumit Kumar, Ashok Kumar Janmeja & Pawan Gupta. (2018) A human xenobiotic nuclear receptor contributes to nonresponsiveness of Mycobacterium tuberculosis to the antituberculosis drug rifampicin. Journal of Biological Chemistry 293:10, pages 3747-3757.
Crossref
Crossref
Linda S. Steelman, Steve L. Abrams, Peter Ruvolo, Vivian Ruvolo, Lucio Cocco, Stefano Ratti, Alberto M. Martelli, Luca M. Neri, Saverio Candido, Massimo Libra & James A. McCubrey. (2017) Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression. Oncotarget 8:68, pages 113013-113033.
Crossref
Crossref
Kevin P. Forbes, Evguenia Kouranova, Daniel Tinker, Karen Janowski, Doug Cortner, Aaron McCoy & Xiaoxia Cui. (2017) Creation and Preliminary Characterization of Pregnane X Receptor and Constitutive Androstane Receptor Knockout Rats. Drug Metabolism and Disposition 45:10, pages 1068-1076.
Crossref
Crossref